Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
About this item
Full title
Author / Creator
Publisher
London: Informa UK, Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Informa UK, Ltd
Subjects
More information
Scope and Contents
Contents
Immunotherapy of type-I-allergies is regarded as the most efficient treatment option besides allergen avoidance. Different forms of allergen preparations are used as well as different routes of application. Virus-like particles represent a potent vaccine platform with proven immunogenicity and clinical efficacy. The addition of toll-like receptor l...
Alternative Titles
Full title
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_informahealthcare_journals_10_1586_1744666X_2014_924854
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_informahealthcare_journals_10_1586_1744666X_2014_924854
Other Identifiers
ISSN
1744-666X
E-ISSN
1744-8409
DOI
10.1586/1744666X.2014.924854
